Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prophylactic 2-week glecaprevir/pibrentasvir in hepatitis C positive-to-negative kidney transplantation

Nephrology Dialysis Transplantation(2024)10.1093/ndt/gfae271Source: DataRank Database

Prophylactic 2-week glecaprevir/pibrentasvir in hepatitis C positive-to-negative kidney transplantation is a research paper published in Nephrology Dialysis Transplantation (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.28)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Aprajita Mattoo,Perry Hotchkis,Ian S. Jaffe ORCID,Elaina Weldon,Jonathan Berger ORCID

Live enrichment

PubMed:39568065 PMC:PMC12207609 OpenAlex:https://openalex.org/W4404607127

National Institutes of Health

Grant: UL1TR001445

National Center for Advancing Translational Sciences

AbbVie

FWCI

0.28

Citation Percentile

0.6%

Citation Trend

2025

greenLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12207609/pdf/gfae271.pdf

publisherhttps://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfae271/60935982/gfae271.pdf

publisherhttps://academic.oup.com/ndt/article-pdf/40/7/1322/60935982/gfae271.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12207609

Fields of Study

Hepatitis C virus researchHIV/AIDS drug development and treatmentCytomegalovirus and herpesvirus research

MeSH Terms

AdultAgedAminoisobutyric AcidsAntiviral AgentsBenzimidazolesCyclopropanesDrug CombinationsFemaleFollow-Up StudiesGraft SurvivalHepatitis CHumansKidney Failure, ChronicLeucineMaleMiddle AgedPilot ProjectsPrognosisProlineProspective StudiesPyrrolidinesQuinoxalinesRNA, ViralSulfonamidesKidney TransplantationHepacivirusViral LoadLactams, Macrocyclic

Keywords

MedicineInternal medicineKidney transplantationHepatitis CGastroenterologyTransplantationProphylactic TreatmentGlecaprevir/pibrentasvirHepatitis C Viremia

Sustainable Development Goals

SDG 0: Good health and well-being